Functional gonads are mandatory for sexual reproduction and survival of higher animal species. However, at the level of the individual subject, acquired or inherited gonadal dysfunction and infertility are not commonly associated with severe life-threatening phenotypes. Medical progress and increased societal interest have led to more prioritised agendas for reproductive health problems. Increasing attention is focused on disorders of sex development, fertility and sexual function. Despite this engagement, our understanding of the detailed molecular and cellular adverse events behind such problems is still incomplete. Critical early steps, such as determination of the gonads, occur at precise temporal windows of development. The sex chromosomes are obvious critical contributors, but many other human chromosomes also contribute to sex differentiation, engaging multiple genes and proteins. The aim of this review is to give an up-to-date and comprehensive summary of the events required for gonadal ontogenesis in the human male, from the stage of embryonic sex determination to postnatal maturation including puberty. The principal genes involved in these processes are tabulated and discussed. Morphological events relevant for human gonadal development are covered, in particular in connection with early germ cell maturation and spermatogenesis. Consequences of maldevelopment caused by, e.g. cryptorchidism, are discussed.

Keywords:
Germ cells, Human spermatogenesis, Somatic cells
1.
Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL: A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125–126 (1999).
2.
Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, et al: Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87:1829–1833 (2002).
3.
Albrecht KH, Eicher EM: Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Dev Biol 204:92–107 (2001).
4.
Amann RP: The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl 29:469–487 (2008).
5.
Anand-Ivell R, Wohlgemuth J, Haren MT, Hope PJ, Hatzinikolas G, et al: Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl 29:618–626 (2006).
6.
Andersson AM, Juul A, Petersen JH, Müller J, Groome NP, et al: Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 82:3976–3981 (1997).
7.
Arango NA, Lovell-Badge R, Behringer RR: Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 99:409–419 (1999).
8.
Auchus RJ: The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 30:101–119 (2001).
9.
Behr R, Weinbauer GF: cAMP response element modulator (CREM): an essential factor for spermatogenesis in primates? Int J Androl 24:126–135 (2001).
10.
Behringer RR, Finegold MJ, Cate RL: Müllerian-inhibiting substance function during mammalian sexual development. Cell 79:415–425 (1994).
11.
Beleza-Meireles A, Lundberg F, Lagerstedt K, Zhou X, Omrani D, et al: FGFR2, FGF8, FGF10 and BMP7 as candidate genes for hypospadias. Eur J Hum Genet 15:405–410 (2007).
12.
Bendel-Stenzel M, Anderson R, Heasman J, Wylie C: The origin and migration of primordial germ cells in the mouse. Semin Cell Dev Biol 9:393–400 (1998).
13.
Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, et al: Prevalence and natural history of cryptorchidism. Pediatrics 92:44–49 (1993).
14.
Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffiths BL, et al: Genetic evidence equating SRY and the testis-determining factor. Nature 348:448–450 (1990).
15.
Biason-Lauber A, Konrad D: WNT4 and sex development. Sex Dev 2:210–218 (2008).
16.
Biason-Lauber A, Schoenle EJ: Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 67:1563–1568 (2000).
17.
Birk OS, Casiano DE, Wassif CA, Cogliati T, Zhao L, et al: The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 403:909–913 (2000).
18.
Boehmer AL, Brinkmann AO, Sandkuijl LA, Halley DJ, Niermeijer MF, et al: 17 Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84:4713–4721 (1999).
19.
Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, et al: Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363:1264–1269 (2004).
20.
Bouma GJ, Albrecht KH, Washburn LL, Recknagel AK, Churchill GA, et al: Gonadal sex reversal in mutant Dax1 XY mice: a failure to upregulate Sox9 in pre-Sertoli cells. Development 132:3045–3054 (2005).
21.
Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, et al: Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 120:758–771 (2007).
22.
Buaas FW, Val P, Swain A: The transcription co-factor CITED2 functions during sex determination and early gonad development. Hum Mol Genet 18:2989–3001 (2009).
23.
Buehr M, McLaren A, Bartley A, Darling S: Proliferation and migration of primordial germ cells in WIWe mouse embryos. Dev Dyn 198:182–189 (1993).
24.
But WM, Lo IFM, Shek CC, Tse WY, Lam ST: Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency. Hong Kong Med J 16:59–62 (2010).
25.
Capel B, Albrecht KH, Washburn LL, Eicher EM: Migration of mesonephric cells into the mammalian gonad depends on Sry. Mech Dev 84:127–131 (1999).
26.
Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP: The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci USA 97:9585–9590 (2000).
27.
Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, et al: Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45:685–698 (1986).
28.
Charest NJ, Zhou ZX, Lubahn DB, Olsen KL, Wilson EM, et al: A frameshift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol Endocrinol 5:573–581 (1991).
29.
Chassot AA, Ranc F, Gregoire EP, Roepers- Gajadien HL, Taketo MM, et al: Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum Mol Genet 17:1264–1277 (2008).
30.
Chemes HE, Gottlieb SE, Pasqualini T, Domenichini E, Rivarola MA, et al: Response to acute hCG stimulation and steroidogenic potential of Leydig cell fibroblastic precursors in humans. J Androl 6:102–112 (1985).
31.
Chemes HE, Cigorraga S, Bergada C, Schteingart H, Rey R, et al: Isolation of human Leydig cell mesenchymal precursors from patients with the androgen insensitivity syndrome: testosterone production and response to human chorionic gonadotropin stimulation in culture. Biol Reprod 46:793–801 (1992).
32.
Cheng CY, Mruk DD: An intracellular trafficking pathway in the seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective. Crit Rev Biochem Mol Biol 44:245–263 (2009).
33.
Cheng YS, Kuo PL, Teng YN, KuoY, Chung CL, et al: Association of spermatogenic failure with decreased CDC25A expression in infertile men. Hum Reprod 21:2346–2352 (2006).
34.
Cigorraga SB, Chemes H, Pellizzari E: Steroidogenic and morphogenic characteristics of human peritubular cells in culture. Biol Reprod 51:1193–1205 (1994).
35.
Claahsen-van der Grinten HL, Hulsbergen-van de Kaa CA, Otten BJ: Ovarian adrenal rest tissue in congenital adrenal hyperplasia–a patient report. J Pediatr Endocrinol Metab 19:177–182 (2006).
36.
Clark AM, Garland KK, Russell LD: Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules. Biol Reprod 63:1825–1838 (2000).
37.
Clermont Y: Two classes of spermatogonial stem cells in the monkey (Cercopithecus aethiops). Am J Anat 126:57–71 (1969).
38.
Colón E, Zaman F, Axelson M, Larsson O, Carlsson-Skwirut C, et al: Insulin-like growth factor-I is an important antiapoptotic factor for rat leydig cells during postnatal development. Endocrinology 148:128–139 (2007).
39.
Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM: Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104:875–889 (2001a).
40.
Colvin JS, White AC, Pratt SJ, Ornitz DM: Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128:2095–2106 (2001b).
41.
Combes AN, Spiller CM, Harley VR, Sinclair AH, Dunwoodie SL, et al: Gonadal defects in Cited2 -mutant mice indicate a role for SF1 in both testis and ovary differentiation. Int J Dev Biol 54:683–689 (2010).
42.
Correa RV, Domenice S, Bingham NC, Billerbeck AE, Rainey WE, et al: A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab 89:1767–1772 (2004).
43.
Cortes D, Kjellberg EM, Breddam M, Thorup J: The true incidence of cryptorchidism in Denmark. J Urol 179:314–318 (2008).
44.
Cotton LM, O’Bryan MK, Hinton BT: Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocr Rev 29:193–216 (2008).
45.
Courant F, Aksglaede L, Antignac JP, Monteau F, Sorensen K, et al: Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method. J Clin Endocrinol Metab 95:82–92 (2010).
46.
Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al: The putative forkhead transcription Factor FOXL2 is mutated in lepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159–166 (2001).
47.
Cupp AS, Uzumcu M, Skinner MK: Chemotactic role of neurotropin 3 in the embryonic testis that facilitates male sex determination. Biol Reprod 68:2033–2037 (2003).
48.
De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, et al: Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 10:1591–1600 (2001).
49.
Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J: The paired-box transcription factor, PAX2, positively modulates expression of the Wilms’ tumor suppressor gene (WT1). Oncogene 13:447–453 (1996).
50.
Dettin L, Ravindranath N, Hofmann MC, Dym M: Morphological characterization of the spermatogonial subtypes in the neonatal mouse testis. Biol Reprod 69:1565–1571 (2003).
51.
de Rooij DG, Grootegoed JA: Spermatogonial stem cells. Curr Opin Cell Biol10:694–701 (1998).
52.
de Rooij DG, Russell LD: All you wanted to know about spermatogonia but were afraid to ask. J Androl21:776–798 (2000).
53.
Di Cerbo A, Biason-Lauber A, Savino M, Piemontese MR, Di Giorgio A, et al: Combined 17 alpha-hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. J Clin Endocrinol Metab 87:898–905 (2002).
54.
Eacker SM, Agrawal N, Qian K, Dichek HL, Gong EY, et al: Hormonal regulation of testicular steroid and cholesterol homeostasis. Mol Endocrinol 22:623–635 (2008).
55.
Edson MA, Nagaraja AK, Matzuk MM: The mammalian ovary from genesis to revelation. Endocr Rev 30:624–712 (2009).
56.
Ehmcke J, Luetjens CM, Schlatt S: Clonal organization of proliferating spermatogonial stem cells in adult males of two species of non-human primates, Macaca mulatta and Callithrix jacchus. Biol Reprod72:293–300 (2005).
57.
Escalier D, Gallo JM, Albert M, Meduri G, Bermudez D, et al: Human acrosome biogenesis: immunodetection of proacrosin in primary spermatocytes and of its partitioning pattern during meiosis. Development 113:779–788 (1991).
58.
Eshkind L, Tian Q, Schmidt A, Franke WW, Windoffer R, et al: Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur J Cell Biol 81:592–598 (2002).
59.
Failli V, Rogard M, Mattei MG, Vernier P, Rétaux S: Lhx9 and Lhx9alpha LIM-homeodomain factors: genomic structure, expression patterns, chromosomal localization, and phylogenetic analysis. Genomics 64:307–317 (2000).
60.
Ferlin A, Arredi B, Zuccarello D, Garolla A, Selice R, et al: Paracrine and endocrine roles of insulin-like factor 3. J Endocrinol Invest 29:657–664 (2006).
61.
Forest MG, Sizonenko PC, Cathiard AM, Bertrand J: Hypophyso-gonadal function in humans during the first year of life. 1. Evidence for testicular activity in early infancy. J Clin Invest 53:819–828 (1974).
62.
Foresta C, Bettella A, Vinanzi C, Dabrilli P, Meriggiola MC, et al: A novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab 89:5952–5958 (2004).
63.
Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, et al: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525–530 (1994).
64.
Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, et al: CXorf6 is a causative gene for hypospadias. Nat Genet 38:1369–1371 (2006).
65.
Ge RS, Shan LX, Hardy MP: Pubertal development of Leydig cells, in Payne AH, Hardy MP, Russell LD, (eds): The Leydig Cell, pp 159–174 (Cache River Press, Vienna 1996).
66.
Ge RS, Dong Q, Sottas CM, Papadopoulos V, Zirkin BR, et al: In search of rat stem Leydig cells: identification, isolation, and lineage-specific development. Proc Natl Acad Sci USA 103:2719–2724 (2006).
67.
Gibbons RJ, Picketts DJ, Villard L, Higgs DR: Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X Syndrome). Cell 80:837–845 (1995).
68.
Goriely A, Hansen RM, Taylor IB, Olesen IA, Jacobsen GK, et al: Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 41:1247–1252 (2009).
69.
Gromoll J, Eiholzer U, Nieschlag E, Simoni M: Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 85:2281–2286 (2000).
70.
Grumbach M: A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 90:3122–3127 (2005).
71.
Hadziselimovic F, Herzog B: The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 358:1156–1157 (2001a).
72.
Hadziselimovic F, Herzog B: Importance of early postnatal germ cell maturation for fertility of cryptorchid males. Horm Res 55:6–10 (2001b).
73.
Hadziselimovic F, Zivkovic D, Bica DT, Emmons LR: The importance of mini-puberty for fertility in cryptorchidism. J Urol 174:1536–1539; discussion 1538–1539 (2005).
74.
Haider SG, Laue D, Schwochau G, Hilscher B: Morphological studies on the origin of adult-type Leydig cells in rat testis. Ital J Anat Embryol 100 Suppl 1:535–541 (1995).
75.
Hanley NA, Ball SG, Clement-Jones M, Hagan DM, Strachan T, et al: Expression of steroidogenic factor 1 and Wilms’ tumour 1 during early human gonadal development and sex determination. Mech Dev 87:175–180 (1999).
76.
Harada D, Yamanaka Y, Ueda K, Tanaka H, Seino Y: FGFR3-related dwarfism and cell signaling. J Bone Miner Metab 27:9–15 (2009).
77.
Hasegawa T, Fukami M, Sato N, Katsumata N, Sasaki G, et al: Testicular dysgenesis without adrenal insufficiency in a 46, XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J Clin Endocrinol Metab 89:5930–5935 (2004).
78.
He Z, Kokkinaki M, Jiang J, Dobrinski I, Dym M: Isolation, characterization, and culture of human spermatogonia. Biol Reprod 82:363–372 (2010).
79.
Heller CG, Clermont Y: Spermatogenesis in man: an estimate of its duration. Science 140:184–186 (1963).
80.
Heller CG, Clermont Y: Kinetics of the germinal epithelium in man. Recent Prog Horm Res 20:545–575 (1964).
81.
Hernández S, Toll A, Baselga E, Ribé A, Azua-Romeo J, et al: Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors. J Invest Dermatol 127:1664–1666 (2007).
82.
Herren T, Gerber PA, Duru F: Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare ‘‘disease of the desmosome’’ with multiple clinical presentations. Clin Res Cardiol 98:141–158 (2009).
83.
Hiort O, Gillessen-Kaesbach G: Disorders of sex development in developmental syndromes. Endocr Dev 14:174–180 (2009).
84.
Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, et al: Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 10:8521–8530 (2004).
85.
Hong SM, Frierson HF Jr, Moskaluk CA: AP-2gamma protein expression in intratubular germ cell neoplasia of testis. Am J Clin Pathol 124:873–877 (2005).
86.
Hossain A, Saunders GF: The human sex-determining gene SRY is a direct target of WT1. J Biol Chem 276:16817–16823 (2001).
87.
Huhtaniemi IT: LH and FSH receptor mutations and their effects on puberty. Horm Res 57 Suppl 2:35–38 (2002).
88.
Huhtaniemi IT, Yamamoto M, Ranta T, Jalkanen J, Jaffe RB: Follicle-stimulating hormone receptors appear earlier in the primate fetal testis than in the ovary. J Clin Endocrinol Metab 65:1210–1214 (1987).
89.
Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, et al: Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol 10:1261–1272 (1996).
90.
Ion A, Telvi L, Chaussain JL, Galacteros F, Valayer J, et al: A novel mutation in the putative DNA helicase XH2 is responsible for male-to-female sex reversal associated with an atypical form of the ATR-X syndrome. Am J Hum Genet 58:1185–1191 (1996).
91.
Ivell R, Hartung S: The molecular basis of cryptorchidism. Mol Hum Reprod 9:175–181 (2003).
92.
Jackson AE, O’Leary PC, Ayers MM, de Kretser DM: The effects of ethylene dimethane sulphonate (EDS) on rat Leydig cells: evidence to support a connective tissue origin of Leydig cells. Biol Reprod 35:425–437 (1986).
93.
Jäger RJ, Anvret M, Hall K, Scherer G: A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature 348:452–454 (1990).
94.
Jagła M, Kruczek P, Kwinta P: Association between X-linked lissencephaly with ambiguous genitalia syndrome and lenticulostriate vasculopathy in neonate. J Clin Ultrasound 36:387–390 (2008).
95.
Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, et al: Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 62:824–833 (1998).
96.
John Radcliffe Hospital Cryptorchidism Study Group: Cryptorchidism: a prospective study of 7500 consecutive male births, 1984–1988. Arch Dis Child 67:892–899 (1992).
97.
Juul A, Aksglaede L, Lund AM, Duno M, Skakkebaek NE, et al: Preserved fertility in a non-mosaic Klinefelter patient with a mutation in the fibroblast growth factor receptor 3 gene: case report. Hum Reprod 22:1907–1911(2007).
98.
Katoh Y, Katoh M: FGFR2-related pathogenesis and FGFR2-targeted therapeutics. Int J Mol Med 23:307–311 (2009).
99.
Kent J, Wheatley SC, Andrews JE, Sinclair AH, Koopman P: A male-specific role for SOX9 in vertebrate sex determination. Development 122:2813–2822 (1996).
100.
Kerr CL, Hill CM, Blumenthal PD, Gearhart JD: Expression of pluripotent stem cell markers in the human fetal testis. Stem cells 26:412–421 (2008).
101.
Ketola I, Rahman N, Toppari J, Bielinska M, Porter-Tinge SB, et al: Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology 140:1470–1480 (1999).
102.
Ketola I, Toppari J, Vaskivuo T, Herva R, Tapanainen JS, et al: Transcription factor GATA-6, cell proliferation, apoptosis, and apoptosis-related proteins Bcl-2 and Bax in human fetal testis. J Clin Endocrinol Metab 88:1858–1865 (2003)
103.
Kim JY, Lee CS, Kim HO, Jo YH, Lee J, et al: The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. Oncol Rep 22:487–492 (2009).
104.
Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, et al: Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4:e187 (2006).
105.
Kitamura K, Yanazawa M, Sugiyama N, Miura H, Iizuka-Kogo A, et al: Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 32:359–369 (2002).
106.
Kollin C, Karpe B, Hesser U, Granholm T, Ritzén EM: Surgical treatment of unilaterally undescended testes: testicular growth after randomization to orchiopexy at age 9 months or 3 years. J Urol 178:1589–1593 (2007).
107.
Kossack N, Simoni M, Richter-Unruh A, Themmen AP, Gromoll J: Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med 5:e88 (2008).
108.
Kostova E, Yeung CH, Leutjens CM, Brune M, Nieschlag E, et al: Association of three isoforms of the meiotic BOULE gene with spermatogenic failure in infertile men. Mol Hum Reprod 13:85–93 (2007).
109.
Krishnamurthy H, Kats R, Danilovich N, Javeshghani D, Sairam MR: Intercellular communication between Sertoli cells and Leydig cells in the absence of follicle-stimulating hormone-receptor signaling. Biol Reprod 65:1201–1207 (2001).
110.
Kristensen DM, Nielsen JE, Skakkebaek NE, Graem N, Jacobsen GK, et al: Presumed pluripotency markers UTF-1 and REX-1 are expressed in human adult testes and germ cell neoplasms. Hum Reprod 23:775–782 (2008).
111.
Kristensen DM, Nielsen JE, Kalisz M, Dalgaard MD, Audouze K, et al: OCT4 and downstream factors are expressed in human somatic urogenital epithelia and in culture of epididymal spheres. Mol Hum Reprod 2010, E-pub ahead of print.
112.
Lei ZM, Mishra S, Zou W, Xu B, Foltz M, et al: Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 15:184–200 (2001).
113.
Lin Y, Liu A, Zhang S, Ruusunen T, Kreidberg JA, et al: Induction of ureter branching as a response to Wnt-2b signaling during early kidney organogenesis. Dev Dyn 222:26–39 (2005).
114.
Loffler KA, Zarkower D, Koopman P: Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocrinology 144:3237–3243 (2003).
115.
Ludbrook LM, Harley VR: Sex determination: a ‘window’ of DAX1 activity. Trends Endocrinol Metab 15:116–121 (2004).
116.
Mallet D, Bretones P, Michel-Calemard L, Dijoud F, David M, et al: Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. J Clin Endocrinol Metab 89:4829–4832 (2004).
117.
Manuylov NL, Smagulova FO, Leach L, Tevosian SG: Ovarian development in mice requires the GATA4-FOG2 transcription complex. Development 135:3731–3743 (2008).
118.
Matsui Y, Zsebo KM, Hogan BL: Embryonic expression of a haematopoietic growth factor encoded by the SI locus and the ligand for c-kit. Nature 347:667–669 (1990).
119.
Matzuk MM, Lamb DJ: The biology of infertility: research advances and clinical challenges. Nat Med 14:1197–1213 (2008).
120.
McLaren A, Southee D: Entry of mouse embryonic germ cells into meiosis. Dev Biol 187:107–113 (1997).
121.
Meistrich ML, van Beek ME: Spermatogonial stem cells, in Desjardins C, Ewing LL (eds): Cell and Molecular Biology of the Testis, pp 266–295 (Oxford University Press, New York 1993).
122.
Merchant Larios H, Moreno Mendoza N: Mesonephric stromal cells differentiate into Leydig cells in the mouse fetal testis. Exp Cell Res 244:230–238 (1998).
123.
Mesiano S, Jaffe RB: Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 18:378–403 (1997).
124.
Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S: Defects of urogenital development in mice lacking Emx2. Development 124:1653–1664 (1997).
125.
Morais da Silva S, Hacker A, Harley V, Goodfellow P, Swain A, et al: Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 14:62–68 (1996).
126.
Morelli MA, Cohen PE: Not all germ cells are created equal: aspects of sexual dimorphism in mammalian meiosis. Reproduction 130:761–781 (2005).
127.
Morohashi K: Gonadal and extragonadal functions of Ad4BP/SF-1: developmental aspects. Trends Endocrinol Metab 10:169–173 (1999).
128.
Motonaga K, Itoh M, Hachiya Y, Endo A, Kato K, et al: Age related expression of Werner’s syndrome protein in selected tissues and coexpression of transcription factors. J Clin Pathol 55:195–199 (2002).
129.
Motro B, van der Kooy D, Rossant J, Reith A, Bernstein A: Contiguous patterns of c-kit and steel expression: analysis of mutations at the W and Sl loci. Development 113:1207–1221 (1991).
130.
Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, et al: Nuclear localization of the protein encoded by the Wilms’ tumor gene WT1 in embryonic and adult tissues. Development 119:1329–1341 (1993).
131.
Nef S, Verma-Kurvari S, Merenmies J, Vassalli JD, Efstratiadis A, et al: Testis determination requires insulin receptor family function in mice. Nature 426:291–295 (2003).
132.
Nishikawa N, Toyota M, Suzuki H, Honma T, Fujikane T, et al: Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res 67:9649–9657 (2007).
133.
Nurmio M, Keros V, Lähteenmäki P, Salmi T, Kallajoki M, et al: Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. J Clin Endocrinol Metab 94:2119–2122 (2009).
134.
Oakberg EF: Duration of spermatogenesis in the mouse. Nature180:1137–1138 (1957).
135.
Oliver-Bonet M, Turek PJ, Sun F, Ko E, Martin RH: Temporal progression of recombination in human males. Mol Hum Reprod 11:517–522 (2005).
136.
O’Shaughnessy PJ, Baker PJ, Johnston H: The foetal Leydig cell – differentiation, function and regulation. Int J Androl 29:90–95 (2006).
137.
O’Shaughnessy PJ, Baker PJ, Monteiro A, Cassie S, Bhattacharya S, et al: Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester. J Clin Endocr Metab 92:4792–4801 (2007a).
138.
O’Shaughnessy PJ, Abel M, Charlton HM, Hu B, Johnston H, et al: Altered expression of genes involved in regulation of vitamin A metabolism, solute transportation, and cytoskeletal function in the androgen-insensitive tfm mouse testis. Endocrinology 148:2914–2924 (2007b).
139.
Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, et al: Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14:2053–2062 (2005).
140.
Park SY, Jamieson JL: Minireview: transcriptional regulation of gonadal development and differentiation. Endocrinology 146:1035–1042 (2005).
141.
Park SY, Lee EJ, Emge D, Jahn CL, Jameson JL: A phenotypic spectrum of sexual development in Dax1 (Nr0b1)-deficient mice: consequence of the C57BL/6J strain on sex determination. Biol Reprod 79:1038–1045 (2008).
142.
Parker KL, Schedl A, Schimmer BP: Gene interactions in gonadal development. Annu Rev Physiol 61:417–433 (1999).
143.
Parma P, Radi O, Vidal V, Chaboissier MC, Dellambra E, et al: R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet 38:1304–1309 (2006).
144.
Pauls K, Schorle H, Jeske W, Brehm R, Steger K, et al: Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochemical study. Hum Reprod 21:397–404 (2006).
145.
Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, et al: Expression of the Wilms’ tumor gene WT1 in the murine urogenital system. Genes Dev 5:1345–1356 (1991a).
146.
Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, et al: WT1 mutations contribute to abnormal genital system development and hereditary Wilms’ tumour. Nature 353:431–434 (1991b).
147.
Person AD, Beiraghi S, Sieben CM, Hermanson S, Neumann AN, et al: WNT5A mutations in patients with autosomal dominant Robinow syndrome. Dev Dyn 239:327–337 (2010).
148.
Pesce M, Farrace MG, Piacentini M, Dolci S, De Felici M: Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 118:1089–1094 (1993).
149.
Petersen C, Söder O: The Sertoli cell – a hormonal target and ‘super’ nurse for germ cells that determines testicular size. Horm Res 66:153–161 (2006).
150.
Petersen C, Boitani C, Froysa B, Söder O: Transforming growth factor-alpha stimulates proliferation of rat Sertoli cells. Mol Cell Endocrinol 181:221–227 (2001).
151.
Petersen C, Boitani C, Froysa B, Söder O: Interleukin-1 is a potent growth factor for immature rat Sertoli cells. Mol Cell Endocrinol 186:37–47 (2002).
152.
Petersen C, Froysa B, Söder O: Endotoxin and proinflammatory cytokines modulate Sertoli cell proliferation in vitro. J Reprod Immunol 61:13–30 (2004).
153.
Pitteloud N, Acierno JS Jr, Meysing A, Eliseenkova AV, Ma J, et al: Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 103:6281–6286 (2006).
154.
Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, et al: The candidate Wilms’ tumour gene is involved in genitourinary development. Nature 346:194–197 (1990).
155.
Prueitt RL, Zinn AR: A fork in the road to fertility. Nat Genet 27:132–134 (2001).
156.
Reijo RA, Dorfman DM, Slee R, Renshaw AA, Loughlin KR, et al: DAZ family proteins exist throughout male germ cell development and transit from nucleus to cytoplasm at meiosis in humans and mice. Biol Repod 63:1490–1496 (2000).
157.
Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, et al: Nordic consensus on treatment of undescended testes. Acta Paediatr 96:638–643 (2007).
158.
Royer-Pokora B, Beier M, Henzler M, Alam R, Schumacher V, et al: Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet A 127A:249–257 (2004).
159.
Ruggieri M, Pavone P, Scapagnini G, Romeo L, Lombardo I, et al: The aristaless (Arx) gene: one gene for many ‘interneuronopathies’. Front Biosci (Elite Ed) 2:701–710 (2010).
160.
Salenave S, Chanson P, Bry H, Pugeat M, Cabrol S, et al: Kallmann’s syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J Clin Endocrinol Metab 93:758–763 (2008).
161.
Schepers G, Wilson M, Wilhelm D, Koopman P: Sox8 is expressed during testis differentiation in mice and synergizes with Sf1 to activate the Amh promoter in vitro. J Biol Chem 278:28101–28108 (2003).
162.
Schepers GE, Bullejos M, Hosking BM, Koopman P: Cloning and characterisation of the Sry-related transcription factor gene Sox8. Nucleic Acids Res 28:1473–1480 (2000).
163.
Schmahl J, Capel B: Cell proliferation is necessary for the determination of male fate in the gonad. Dev Biol 258:264–276 (2003).
164.
Schmahl J, Eicher EM, Washburn LL, Capel B: Sry induces cell proliferation in the mouse gonad. Development 127:65–73 (2000).
165.
Schmahl J, Colvin JS, Ornitz DM, Capel B: Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development 131:3627–3636 (2004).
166.
Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, et al: The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933–942 (2004).
167.
Schulze W, Davidoff MS, Holstein AF: Are Leydig cells of neural origin? Substance P-like immunoreactivity in human testicular tissue. Acta Endocrinol (Copenh) 115:373–377 (1987).
168.
Sekido R, Lovell-Badge R: Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453:930–934 (2008).
169.
Sekido R, Lovell-Badge R: Sex determination and SRY: down to a wink and a nudge? Trends Genet 25:19–29 (2009).
170.
Sharpe RM: Regulation of spermatogenesis, in Knobil E, Neill JD (eds): The Physiology of Reproduction, pp 1363–1394 (Raven Press, New York 1994).
171.
Sharpe RM: Perinatal determinants of adult testis size and function. Editorial. JCEM 91:2503–2505 (2006).
172.
Sharpe RM, McKinnell C, Kivlin C, Fisher JS: Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125:769–784 (2003).
173.
Shawlot W, Behringer RR: Requirement for Lim1 in head-organizer function. Nature 374:425–430 (1995).
174.
Simard J, Ricketts ML, Moisan AM, Tardy V, Peter M, et al: A new insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency. Endocr Res 26:761–770 (2000).
175.
Simoni M, Gromoll J, Nieschlag E: The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773 (1997).
176.
Söder O: Sexual dimorphism of gonadal development. Best Pract Res Clin Endocrinol Metab 21:381–391 (2007).
177.
Steger K, Pauls K, Klonisch T, Franke FE, Bergmann M: Expression of protamine-1 and-2 mRNA during human spermiogenesis. Mol Hum Reprod 6:219–225 (2000).
178.
Stikkelbroeck NM, Otten BJ, Pasic A, Jager GJ, Sweep CG, et al: High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:5721–5728 (2001).
179.
Stocco DM: StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63:193–213 (2001).
180.
Svechnikov K, Landreh L, Weisser J, Izzo G, Colón E, et al: Origin, development and regulation of human Leydig cells. Horm Res Paediatr 73:93–101 (2010).
181.
Tajima T, Fujieda K, Kouda N, Nakae J, Miller WL: Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86:3820–3825 (2001).
182.
Taketo M, Parker KL, Howard TA, Tsukiyama T, Wong M, et al: Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. Genomics 25:565–567 (1995).
183.
Tan KA, De Gendt K, Atanassova N, Walker M, Sharpe RM, et al: The role of androgens in sertoli cell proliferation and functional maturation: studies in mice with total or sertoli cell-selective ablation of the androgen receptor. Endocrinology 146:2674–2683 (2005).
184.
Teerds KJ, De Rooij DG, Rommerts FF, Wensing CJ: The regulation of the proliferation and differentiation of rat Leydig cell precursor cells after EDS administration or daily HCG treatment. J Androl 9:343–351 (1988).
185.
Tellier AL, Amiel J, Delezoide AL, Audollent S, Augé J, et al: Expression of the PAX2 gene in human embryos and exclusion in the CHARGE syndrome. Am J Med Genet 93:85–88 (2000).
186.
Thummer RP, Drenth-Diephuis LJ, Carney KE, Eggen BJ: Functional characterization of single-nucleotide polymorphisms in the human undifferentiated embryonic-cell transcription factor 1 gene. DNA Cell Biol 29:241–248 (2010).
187.
Tomaselli S, Megiorni F, De Bernardo C, Felici A, Marrocco G, et al: Syndromic true hermaphroditism due to an R-spondin1 (RSPO1) homozygous mutation. Hum Mutat 29:220–226 (2008).
188.
Torres M, Gómez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple steps of urogenital development. Development 121:4057–4065 (1995).
189.
Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, et al: Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139:1130–1142 (2009).
190.
Vainio S, Heikkilä M, Kispert A, Chin N, McMahon AP: Female development in mammals is regulated by WNT-4 signalling. Nature 397:405–409 (1999).
191.
van Alphen MM, van de Kant HJ, de Rooij DG: Follicle-stimulating hormone stimulates spermatogenesis in the adult monkey. Endocrinology 123:1449–1455 (1988).
192.
Vidal VP, Chaboissier MC, de Rooij DG, Schedl A: Sox9 induces testis development in XX transgenic mice. Nat Genet 28:216–217 (2001).
193.
Viger RS, Silversides DW, Tremblay JJ: New insights into the regulation of mammalian sex determination and male sex differentiation. Vitam Horm 70:387–413 (2005).
194.
Volcik KA, Zhu H, Finnell RH, Shaw GM, Canfield M, et al: Evaluation of the Cited2 gene and risk for spina bifida and congenital heart defects. Am J Med Genet A 126A:324–325 (2004).
195.
von Kopylow K, Kirchhoff C, Jezek D, Schulze W, Feig C, et al: Screening for biomarkers of spermatogonia within the human testis: a whole genome approach. Hum Reprod 25:1104–1112 (2010).
196.
Wang Y, Barthold J, Kanetsky PA, Casalunovo T, Pearson E, et al: Allelic variants in HOX genes in cryptorchidism. Birth Defects Res A Clin Mol Teratol 79:269–275 (2007).
197.
Wikstrom AM, Bay K, Hero M, Andersson AM, Dunkel L: Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome. J Clin Endocrinol Metab 91:4705–4708 (2006).
198.
Wilhelm D, Washburn LL, Truong V, Fellous M, Eicher EM, et al: Antagonism of the testis- and ovary-determining pathways during ovotestis development in mice. Mech Dev 126:324–336 (2009).
199.
Wistuba J, Stukenborg JB, Luetjens CM: Mammalian spermatogenesis. Funct Dev Embryol 1:99–117 (2007).
200.
Wood HM, Elder JS: Cryptorchidism and testicular cancer: separating fact from fiction. J Urol 181:452–461 (2009).
201.
Wylie C: Germ cells. Cell 96:165–174 (1999).
202.
Yan W, Kero J, Huhtaniemi I, Toppari J: Stem cell factor functions as a survival factor for mature Leydig cells and a growth factor for precursor Leydig cells after ethylene dimethane sulfonate treatment: implication of a role of the stem cell factor/c-Kit system in Leydig cell development. Dev Biol 227:169–182 (2000).
203.
Yu RN, Ito M, Saunders TL, Camper SA, Jameson JL: Role of Ahch in gonadal development and gametogenesis. Nat Genet 20:353–357 (1998).
204.
Zhengwei Y, McLachlan RI, Bremner WJ, Wreford NG: Quantitative (stereological) study of the normal spermatogenesis in the adult monkey (Macaca fascicularis). J Androl 18:681–687 (1997).
205.
Zivkovic D, Bica DT, Hadziselimovic F: Relationship between adult dark spermatogonia and secretory capacity of Leydig cells in cryptorchidism. Paediatr Urol 100:1147–1149 (2007).
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.